Hépato-Gastro & Oncologie Digestive
MENURadioembolization for intra-hepatic cholangiocarcinoma and liver metastasis of colorectal cancer: where are we now? Volume 24, issue 2, Février 2017
Authors
1 Centre Eugène Marquis,
service d’oncologie médicale,
Rue de la Bataille Flandres Dunkerque,
35000 Rennes,
France
service d’oncologie médicale,
Rue de la Bataille Flandres Dunkerque,
35000 Rennes,
France
2 Centre Eugène Marquis,
service de radiodiagnostic et radiologie interventionnelle,
Rue de la Bataille Flandres Dunkerque,
35000 Rennes,
France
service de radiodiagnostic et radiologie interventionnelle,
Rue de la Bataille Flandres Dunkerque,
35000 Rennes,
France
3 Centre Eugène Marquis,
service de médecine nucléaire,
Rue de la Bataille Flandres Dunkerque,
35000 Rennes,
France
service de médecine nucléaire,
Rue de la Bataille Flandres Dunkerque,
35000 Rennes,
France
* Tirés à part
- Key words: selective internal radiation therapy, biliary tract cancer, liver metastases, colorectal cancer
- DOI : 10.1684/hpg.2017.1407
- Page(s) : 121-8
- Published in: 2017
Selective internal radiation therapy has been developed since the 80’ with various vectors (lipiodol, micro beads) and radionuclides (131I, 90Y, 88Re). This therapeutic option is now ready for daily practice in several primary liver tumors as well as in liver metastases. Its definitive position in the future therapeutic guidelines will depend on the results of the ongoing phase 2 and 3 clinical trials. Here, we review the available data concerning selective internal radiation therapy and mass-forming cholangiocarcinoma on one hand and colorectal cancer liver metastases on the other hand.